Treatment of Toxic Epidermal Necrolysis With High-Dose Intravenous Immunoglobulins-Reference-Cited by-同舟云学术

Treatment of Toxic Epidermal Necrolysis With High-Dose Intravenous Immunoglobulins

Published:2003-01-01 Issue:1 Volume:139 Page:26
ISSN:0003-987X
Container-title:Archives of Dermatology
language:en
Short-container-title:Arch Dermatol

Author:

Prins Christa,Kerdel Francisco A.,Padilla R. Steven,Hunziker Thomas,Chimenti Sergio,Viard Isabelle,Mauri Davide N.,Flynn Kirsten,Trent Jennifer,Margolis David J.,Saurat Jean-Hilaire,French Lars E.,

Publisher

American Medical Association (AMA)

Subject

Dermatology,General Medicine

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/479146/dst10203_26_32.pdf

Reference27 articles.

1. Severe adverse cutaneous reactions to drugs.;Roujeau;N Engl J Med,1994

2. Toxic epidermal necrolysis.;Becker;Lancet,1998

3. Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients.;Revuz;Arch Dermatol,1987

4. Toxic epidermal necrolysis (Lyell syndrome): incidence and drug etiology in France, 1981-1985.;Roujeau;Arch Dermatol,1990

5. Toxic epidermal necrolysis and Stevens-Johnson syndrome: an epidemiologic study from West Germany.;Schöpf;Arch Dermatol,1991

Cited by 280 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute and chronic ocular outcomes in SJS/TEN patients treated with oral ciclosporin vs intravenous immunoglobulin;Frontiers in Medicine;2024-08-19

2. Severe Cutaneous Adverse Reactions to Drugs;Rook's Textbook of Dermatology;2024-03-19

3. Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia;Journal of Small Animal Practice;2024-01-19

4. An individual patient data meta‐analysis of wound care in patients with toxic epidermal necrolysis;Australasian Journal of Dermatology;2023-12-08

5. Pembrolizumab-Associated Stevens-Johnson Syndrome in a Patient With Metastatic Non-small Cell Lung Cancer: A Case Report;Cureus;2023-07-06